Found 46 with Last Name = 'ennis' and Initial = 'c' 
Affinity DataIC50: 100nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 490nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 820nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 890nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 940nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.29E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 2.02E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 2.49E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 2.90E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 5.09E+3nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.30E+3nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.12E+4nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.18E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.28E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.95E+4nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 4.01E+4nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.38E+4nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.97E+4nMAssay Description:Inhibition of human DDX3X using dsRNA as substrate measured every 30 sec for 40 mins by FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.20E+4nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.15E+5nMAssay Description:Inhibition of Thromboxane A2 synthetase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.25E+5nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of Thromboxane A2 synthase after oral administration of 0.03 mmol/kgMore data for this Ligand-Target Pair
